Philip Rowlings

Publishing 2016–2020

Is this you? Claim this profile
10
Articles
4,244
Reads on Journament
124
Co-authors
8
Journals

This page collects the articles indexed under the name Philip Rowlings. Profiles are grouped by name, so it can include work by someone else who shares it until the author claims the profile and confirms which papers are theirs.

Publications 10

  1. Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantation.
    Leukemia & lymphoma 2020 420 reads Calvary Mater Newcastle Hospital
  2. Clinical use of SNP-microarrays for the detection of genome-wide changes in haematological malignancies.
  3. Quality of life is maintained with ixazomib maintenance in post-transplant newly diagnosed multiple myeloma: the TOURMALINE-MM3 trial.
    European journal of haematology 2019 404 reads University of Newcastle Australia
  4. 'Real-world' Australian experience of pomalidomide for relapsed and refractory myeloma.
    Leukemia & lymphoma 2018 424 reads Calvary Mater Newcastle Hospital
  5. Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.
  6. Evaluation of cardiovascular ischemic event rates in dasatinib-treated patients using standardized incidence ratios.
    Annals of hematology 2017 422 reads Calvary Mater Newcastle Hospital
  7. Detection of complex genomic signatures associated with risk in plasma cell disorders.
    cancer genetics 2017 345 reads
  8. To adhere or not to adhere: Rates and reasons of medication adherence in hematological cancer patients.
    Critical reviews in oncology/hematology 2016 359 reads Calvary Mater Newcastle Hospital
  9. Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic Regions.
  10. A systematic evaluation of the safety and toxicity of fingolimod for its potential use in the treatment of acute myeloid leukaemia.
    anti-cancer drugs 2016 463 reads Hunter Cancer Research Alliance

Is this you?

Claim this profile to connect it to your account. You will be able to remove papers that are not yours, fold in other spellings of your name, and show your affiliation and photo here.

An admin reviews every claim. Your account's name, email address and affiliation are shown to them too.

You need an account to claim. No password: we email you a sign-in link, and your claim is sent as soon as you are back.

Institutions on these papers

  • Calvary Mater Newcastle Hospital · AU 4
  • University of Newcastle Australia · AU 2
  • The University of Sydney · AU 1
  • Hunter Cancer Research Alliance · AU 1

From OpenAlex, for papers with a DOI.

Frequent co-authors

Publishes in